ARTICLE | Clinical News
Silodyx/Urorec silodosin regulatory update
February 8, 2010 8:00 AM UTC
The EC approved an MAA from Recordati for Silodyx/Urorec silodosin to treat signs and symptoms of benign prostatic hyperplasia (BPH). Recordati plans to launch the selective adrenergic receptor alpha...